Instil Bio, Inc. (TIL)
7.58
-0.08
(-1.04%)
USD |
NASDAQ |
Sep 04, 16:00
7.58
0.00 (0.00%)
After-Hours: 20:00
Instil Bio Total Liabilities (Quarterly) : 90.33M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 90.33M |
| March 31, 2026 | 89.73M |
| December 31, 2025 | 91.80M |
| September 30, 2025 | 91.35M |
| June 30, 2025 | 99.32M |
| March 31, 2025 | 92.54M |
| December 31, 2024 | 95.32M |
| September 30, 2024 | 96.23M |
| June 30, 2024 | 99.30M |
| March 31, 2024 | 100.48M |
| December 31, 2023 | 99.80M |
| September 30, 2023 | 106.25M |
| Date | Value |
|---|---|
| June 30, 2023 | 111.79M |
| March 31, 2023 | 116.02M |
| December 31, 2022 | 118.52M |
| September 30, 2022 | 122.15M |
| June 30, 2022 | 110.20M |
| March 31, 2022 | 56.38M |
| December 31, 2021 | 54.78M |
| September 30, 2021 | 45.98M |
| June 30, 2021 | 37.20M |
| March 31, 2021 | 30.99M |
| December 31, 2020 | 26.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 197.71M |
| Shareholders Equity (Quarterly) | 107.38M |
| Debt to Equity Ratio | 0.8141 |
| Current Ratio | 21.67 |
| Net Debt Paydown Yield | -0.29% |